Cirrhosis
Conditions
Interventions
Divided into different groups based on liver function grading and treatment methods:None
Sponsors
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Cirrhotic portal hypertension was confirmed by clinical manifestation, laboratory examination, imaging examination or liver biopsy; 2. Patients who intend to receive drug therapy, endoscopic therapy or interventional therapy for portal hypertension; 3. Age 18-75 years old; 4. The patient and his family agreed to review the items before and after treatment
Exclusion criteria
Exclusion criteria: 1. Over 75 years of age; 2. Advanced liver cancer or other malignant diseases; 3. Portal vein thrombosis (greater than 50%); 4. Child - Pugh score >14 points or MELD score >30 points; 5. Contraindications of NSBB; 6. Severe coronary heart disease, hypertension or cardiopulmonary failure; 7. The researcher thinks that it is not suitable to participate in this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of gastrointestinal bleeding;Incidence of hepatic encephalopathy;Incidence of ascites;The incidence of adverse reactions and complications in various treatments; | — |
Countries
China
Contacts
Public ContactGuangchuan Wang
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Outcome results
None listed